The group's principal activities are to develop, manufacture and market generic prescription strength and over-the-counter pharmaceutical products. It currently manufactures and markets nineteen generic drug products in solid dosage form. All of the products that the group manufactures are of solid oral dosage form, consisting of tablets, caplets and capsules. The group sells its products under its own label and also through wholesalers and distributors who sell its products under their own labels. The group operates mostly in the United States of America.
